SUMMIT, NJ — When treated in its earliest stages, the five-year survival rate for ovarian cancer is over 90 percent. However, only 15 percent of cases are found at this early stage due to ovarian cancer's non-specific symptoms and lack of available early detection tests.
When discovered at a more advanced stage, the ovarian cancer survival rate can be as low as 18 percent.
The Women's Cancer Center at Carol G. Simon Cancer Center at Overlook Medical Center and Morristown Medical Center is evaluating periodic blood tests that may be helpful in the early detection of ovarian cancer.
Ovarian Cancer Screening Trial recruitment days for new patients will take place from 9 a.m. to 2 p.m. at:
- Chilton Medical Center: July 17
- Overlook Medical Center: July 19
- Newton Medical Center: July 27
- Morristown Medical Center: August 4
Are you Eligible?
This study is available for women between 50 and 74 years old who:
- Are post-menopausal
- Are not and have not been in cancer treatment for the past 12 months (talk to study coordinator for exceptions)
- Have at least one ovary
- Have a health care provider
- Telephone interview
- Blood test (annually or more often, if indicated)
- Medical history questionnaire and surveys
- Transvaginal ultrasounds (for some participants)
- Receive possible ovarian cancer screening test at no cost
- Contribute valuable information to medical research
Why Join a Research Study?
Research studies, also known as clinical trials, are the most effective tools for evaluating new ways to prevent and treat cancer. Because of research studies, many people with cancer are living longer and enjoying a better quality of life.
By participating in cancer research, individuals advance medical science and help others who will battle cancer in the future.
To participate, or for more information, call 973-971-6491 or contact Ovarian.Screening@atlantichealth.org.